ARTICLE | Company News
Sparta deal
October 10, 1994 7:00 AM UTC
The Durham, N.C., company obtained a U.S. license for RII Retinamide to treat myelodysplastic syndromes (MDS) from BASF Actiengesellschaft (Germany). MDS is a group of conditions that share an abnorma...